Compare NeoGenomics Inc. Common Stock (NEO) vs PubMatic Inc (PUBM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs PubMatic Inc — how do they compare? NeoGenomics Inc. Common Stock trades at $16.85 (market cap $2.14B), while PubMatic Inc trades at $17.61 (market cap $860.90M). The key difference: NeoGenomics Inc. Common Stock is far larger — about 2.5× PubMatic Inc's market cap, and PubMatic Inc is trading nearer its 52-week high, NeoGenomics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and PubMatic Inc for 40 Days on average.
| NEO | PUBM | |
|---|---|---|
Market Cap | $2.14B | $860.90M |
Volume | 2,228,400 | 528,167 |
Sector | Health | Technology |
52-Week High | $19.91 | $19.18 |
52-Week Low | $7.19 | $6.28 |
Typical Hold Time | 0 Days | 40 Days |
Enterprise Value | $2.44B | $764.03M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PUBM trades at $17.64, down 4.75% today but maintains strong technical momentum with bullish moving average signals. The company reported three consecutive quarterly EPS beats despite negative annual net income margins. Recent Q2 2026 results showed 10.5% revenue growth and a significant EPS beat of $0.12 versus $0.03 expected, driven by mobile app and CTV segment strength.
Wall Street maintains bullish sentiment with 11 buy ratings and a $19.89 consensus target, representing 13% upside. Key risks include CFO transition uncertainty and competitive ad-tech landscape pressure. The stock's premium valuation (P/E 132) requires continued execution on AI-driven growth initiatives to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About PubMatic Inc
PubMatic Inc is engaged in the digital advertising business. The company provides a specialized cloud infrastructure platform that enables real-time programmatic advertising transactions. The platform helps independent app developers and publishers to control and maximize their digital advertising businesses.
Read more on PUBM →
